Bristol John W & Co Inc decreases stake in Novartis AG (NYSE:NVS) by $1,747,000
According to the most recent 13F filing with the SEC dated February 03, 2016, institutional investor Bristol John W & Co Inc reduced its stake in Novartis AG (NYSE:NVS) by -2.66% during the forth quarter ending December 31st, 2015. Bristol John W & Co Inc now owns 860,714 shares of company's stock after selling 23,520 shares during the quarter worth about $1,747,000. Bristol John W & Co Inc holdings in Novartis AG were worth $63,977,000 at the end of the most recent reporting period. Novartis AG (NYSE:NVS) accounts for approximately 0.0184% of Bristol John W & Co Inc holdings.
Among institutional investors, the top 3 institutions holding most of NVS stock are: DODGE & COX (1.68%), PRIMECAP MANAGEMENT CO/CA/ (0.75%) and BROWN BROTHERS HARRIMAN & CO (0.34%). DODGE & COX holds the most number of Novartis AG shares to the amount of 45,723,035 which are worth about 3,398,593 as of September 30, 2015. During this period, DODGE & COX decreased its holding by about -4.69% worth about $167,042,552 or (2,247,310) shares.
Among institutional investors decreasing their stake in NVS, FMR LLC decreased its holding by about -73.96% worth about $297,818,754 or 4,006,710 shares. DODGE & COX decreased its holding by about -4.69% worth about $167,042,552 or 2,247,310 shares. PRIMECAP MANAGEMENT CO/CA/ decreased its holding by about -5.97% worth about $98,290,275 or 1,322,350 shares.
Among institutional investors selling out all their stake in NVS, TIAA CREF INVESTMENT MANAGEMENT LLC sold out all its holding worth about $17,586,626 or 236,602 shares. TELEMARK ASSET MANAGEMENT, LLC sold out all its holding worth about $10,406,200 or 140,000 shares. STATE OF TENNESSEE, TREASURY DEPARTMENT sold out all its holding worth about $10,034,550 or 135,000 shares.
Novartis AG (NYSE:NVS) Institutional Ownership
| Institutional Ownership | 08.88% |
|---|---|
| Total Shares Outstanding (millions) | 2,677 |
| Total Value of Holdings (millions) | $17,669 |
Novartis AG (NYSE:NVS) Institutional Positions
| HOLDERS | SHARES | |
| Increased Positions | 392 | 20,063,490 |
| Decreased Positions | 398 | 17,324,740 |
| Held Positions | 190 | 200,327,347 |
| Total Institutional Shares | 980 | 237,715,577 |
Top 15 Decreased Institutional Holdings for Novartis AG (NVS)
| Owner Name | Quarter Ending | Shared Held | Overall Stake | Shares Sold ^ | Shares Sold (%) | Value (in 1,000s) |
|---|---|---|---|---|---|---|
| FMR LLC | 09/30/2015 | 1,410,688 | 0.04% | 4,006,710 | -73.96 | 104,856 |
| DODGE & COX | 09/30/2015 | 45,723,035 | 1.68% | 2,247,310 | -4.69 | 3,398,593 |
| PRIMECAP MANAGEMENT CO/CA/ | 09/30/2015 | 20,815,508 | 0.75% | 1,322,350 | -5.97 | 1,547,217 |
| BAHL & GAYNOR INC | 09/30/2015 | 860,944 | 0.0% | 855,516 | -49.84 | 63,994 |
| NORTHERN TRUST CORP | 09/30/2015 | 3,551,038 | 0.11% | 627,875 | -15.03 | 263,949 |
| WESTWOOD HOLDINGS GROUP INC | 09/30/2015 | 5,150 | 0.0% | 582,336 | -99.12 | 383 |
| WHV INVESTMENTS, INC. | 12/31/2015 | 1,113,091 | 0.04% | 490,385 | -30.58 | 82,736 |
| BROWN BROTHERS HARRIMAN & CO | 09/30/2015 | 9,291,495 | 0.34% | 433,374 | -4.46 | 690,637 |
| AMERIPRISE FINANCIAL INC | 09/30/2015 | 1,341,342 | 0.04% | 369,180 | -21.58 | 99,702 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 09/30/2015 | 21,758 | 0.0% | 339,500 | -93.98 | 1,617 |
| INVESCO LTD. | 09/30/2015 | 2,197,619 | 0.07% | 300,611 | -12.03 | 163,349 |
| JENNISON ASSOCIATES LLC | 09/30/2015 | 514,039 | 0.0% | 263,592 | -33.9 | 38,209 |
| BANK OF NEW YORK MELLON CORP | 09/30/2015 | 1,278,761 | 0.04% | 240,006 | -15.8 | 95,050 |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 09/30/2015 | 0 | 0.0% | 236,602 | Sold Out | N/A |
| STIFEL NICOLAUS & CO INC \MO\ | 09/30/2015 | 239,945 | 0.0% | 224,805 | -48.37 | 17,835 |
Novartis AG (NYSE:NVS) New and Sold Out Institution Positions
| HOLDERS | SHARES | |
| New Positions | 47 | 692,375 |
| Sold Out Positions | 62 | 1,144,769 |
Top 15 Sold Out Institutional Holders for Novartis AG (NYSE:NVS)
| Owner Name | Quarter Ending | Shared Held | Shares Sold ^ | Shares Sold (%) |
|---|---|---|---|---|
| TIAA CREF INVESTMENT MANAGEMENT LLC | 09/30/2015 | 0 | 236,602 | Sold Out |
| TELEMARK ASSET MANAGEMENT, LLC | 09/30/2015 | 0 | 140,000 | Sold Out |
| STATE OF TENNESSEE, TREASURY DEPARTMENT | 09/30/2015 | 0 | 135,000 | Sold Out |
| COLUMBUS CIRCLE INVESTORS | 12/31/2015 | 0 | 124,409 | Sold Out |
| PIONEER INVESTMENT MANAGEMENT INC | 09/30/2015 | 0 | 83,144 | Sold Out |
| BALYASNY ASSET MANAGEMENT LLC | 09/30/2015 | 0 | 50,000 | Sold Out |
| HUSSMAN STRATEGIC ADVISORS, INC. | 12/31/2015 | 0 | 50,000 | Sold Out |
| BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. | 09/30/2015 | 0 | 49,092 | Sold Out |
| ENDURANT CAPITAL MANAGEMENT LP | 09/30/2015 | 0 | 42,200 | Sold Out |
| CHARTWELL INVESTMENT PARTNERS, LLC | 12/31/2015 | 0 | 24,480 | Sold Out |
| FIRST NEW YORK SECURITIES LLC /NY | 12/31/2015 | 0 | 22,500 | Sold Out |
| VIDENT INVESTMENT ADVISORY, LLC | 09/30/2015 | 0 | 18,190 | Sold Out |
| STATE TREASURER STATE OF MICHIGAN | 12/31/2015 | 0 | 14,800 | Sold Out |
| EISNERAMPER WEALTH MANAGEMENT CORPORATE BENEFITS, LLC | 12/31/2015 | 0 | 13,386 | Sold Out |
| QUADRATURE CAPITAL LTD | 09/30/2015 | 0 | 11,600 | Sold Out |
Top 15 Institutional Holders for Novartis AG (NYSE:NVS)
| Owner Name | Quarter Ending | Shared Held | Overall Stake | Change (Shares) | Change (%) | Value (in 1,000s) ^ |
|---|---|---|---|---|---|---|
| DODGE & COX | 09/30/2015 | 45,723,035 | 1.68% | (2,247,310) | -4.69 | 3,398,593 |
| PRIMECAP MANAGEMENT CO/CA/ | 09/30/2015 | 20,815,508 | 0.75% | (1,322,350) | -5.97 | 1,547,217 |
| BROWN BROTHERS HARRIMAN & CO | 09/30/2015 | 9,291,495 | 0.34% | (433,374) | -4.46 | 690,637 |
| WELLS FARGO & COMPANY/MN | 09/30/2015 | 7,605,758 | 0.26% | (120,124) | -1.56 | 565,336 |
| FRANKLIN RESOURCES INC | 09/30/2015 | 7,053,040 | 0.26% | 3,397,863 | 92.96 | 524,252 |
| FISHER ASSET MANAGEMENT, LLC | 12/31/2015 | 6,188,893 | 0.22% | 56,682 | .92 | 460,020 |
| BANK OF AMERICA CORP /DE/ | 09/30/2015 | 5,648,680 | 0.19% | 3,331,488 | 143.77 | 419,866 |
| UBS GROUP AG | 09/30/2015 | 4,980,552 | 0.15% | (146,875) | -2.86 | 370,204 |
| LOOMIS SAYLES & CO L P | 09/30/2015 | 4,600,090 | 0.15% | 322,926 | 7.55 | 341,925 |
| MANAGED ACCOUNT ADVISORS LLC | 06/30/2015 | 3,859,095 | 0.11% | (41,653) | -1.07 | 286,847 |
| INSTITUTIONAL CAPITAL LLC | 09/30/2015 | 3,838,075 | 0.11% | 2,286,491 | 147.37 | 285,284 |
| NORTHERN TRUST CORP | 09/30/2015 | 3,551,038 | 0.11% | (627,875) | -15.03 | 263,949 |
| MANNING & NAPIER ADVISORS LLC | 12/31/2015 | 3,507,436 | 0.11% | 727,330 | 26.16 | 260,708 |
| STATE STREET CORP | 09/30/2015 | 3,345,575 | 0.11% | 3,332,007 | 24,557.84 | 248,677 |
| MAWER INVESTMENT MANAGEMENT LTD. | 12/31/2015 | 2,868,583 | 0.07% | 358,567 | 14.29 | 213,222 |
Novartis AG (NYSE:NVS) Quick Overview on Saturday, February 06 2016 (07:30PM EST)
Novartis AG stock is currently trading at $74.33 (as of 2/5/2016 4:02pm EST). The current asking price for NVS is $74.33 and bid price is $72.52. The NVS stock is DOWN by $-0.73 (or -0.97%) after trading opened at 9:30am EST at the opening price of $74.96. Today's high so far has been $75.08 and the low has been $73.97 with the day's price range fluctuating between $73.97 - 75.08 (or -0.73 - -0.97%). The current trading volume for the day has been 2306699 shares so far. The average daily trading volume for NVS is 2140560 shares.
Novartis AG (NYSE:NVS) Stock Price Graph for trading day, February 06 2016
Previous trading session performance
The stock has a previous day closing price of $75.06 from its last trading session on February 05, 2016 4:00PM EST.
Overall Yearly performance for Novartis AG
The high for the year 2016 has been $106.84 and the low has been $73.97. The range for the stock for this year has been $73.97 - 106.84 so far. The stock is DOWN from year high by $-32.51 or (-30.43%). The stock is UP from year low by $0.36 or (+0.49%). NVS has a book value of $32.46. The Short Ratio for NVS is 2.64. The Earnings Per Share (EPS) value for NVS is 7.30. The Price to Sales Ratio for Novartis AG is 3.54. NVS has a 50-day moving average of $81.99 and a 200-day moving average of $90.86.
Novartis AG (NYSE:NVS) Stock Price Graph for 2016
Novartis AG (NYSE:NVS) - Company Financials
Novartis AG has a market capitalization of 176.45B. The EBITDA value for Novartis AG is $15.18B. The Price to Earnings ratio (P/E) for NVS is 10.19. The Price/Earnings to growth ratio (PEG) is 2.20.
Novartis AG (NYSE:NVS) Forecast
Novartis AG stock has an estimated Earnings Per Share (EPS) value of 4.81 for the current year of 2016. The EPS for the next quarter is estimated to be 1.17. The EPS for year 2016 is estimated to be 5.38. Analysts have estimated a One Year target price for NVS to be at $97.75.
Posted by
